Prophylactic use of levofloxacin during medicinal leech therapy

International Journal of Clinical Pharmacy

Volumn 36, Issue 5, 2014, Pages 995-999

  Bauters, Tiene ^a   Buyle, Franky ^a   Blot, Stijn ^b   Robays, Hugo ^a   Vogelaers, Dirk ^a   Van Landuyt, Koen ^a   Vanhove, Wim ^a   Claeys, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Aeromonas species; Antibiotic prophylaxis; Hirudo medicinalis; Leech therapy; Levofloxacin

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AEROMONAS; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BELGIUM; BLOOD SMEAR; CHILD; COST CONTROL; DRUG COST; FEMALE; HIRUDO MEDICINALIS; HUMAN; INFECTION PREVENTION; LEECHING; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; SURGICAL INFECTION; ADVERSE EFFECTS; ANTIBIOTIC PROPHYLAXIS; COST BENEFIT ANALYSIS; DRUG EFFECTS; ECONOMICS; GRAM-NEGATIVE BACTERIAL INFECTIONS; MIDDLE AGED; UTILIZATION; YOUNG ADULT;

ADOLESCENT; ADULT; AEROMONAS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; COST-BENEFIT ANALYSIS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GUIDELINE ADHERENCE; HUMANS; LEECHING; LEVOFLOXACIN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84911392799     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-014-9986-x     Document Type: Article

References (20)

1. Abdelgabar AM, Bhowmick BK. The return of the leech. Int J Clin Pract. 2003;57(2):103–5.
2. Ernst E. Born to suck–the return of the leech? Pain. 2008;137(2):235–6.
3. Schnabl S, Kunz C, Unglaub F, Polykandriotis E, Horch R, Dragu A. Acute postoperative infection with Aeromonas hydrophila after using medical leeches for treatment of venous congestion. Arch Orthop Trauma Surg. 2010;130:1323–8.
4. Whitaker IS, Elmiyeh B, Wright DJ. Hirudo medicinalis: the need for prophylactic antibiotics. Plast Reconstr Surg. 2003;112:1185–6.
5. Sartor C, Limouzin-Perotti F, Legré R, Casanova D, Bongrand M, Sambuc R, et al. Nosocomial infections with Aeromonashydrophila from leeches. Clin Infect Dis. 2002;35:E1–5.
6. Wang EW, Warren DK, Ferris VM, Casabar E, Nussenbaum B. Leech-transmitted ciprofloxacin-resistant Aeromonas hydrophila. Arch Otolaryngol Head Neck Surg. 2011;137(2):190–3.
7. Mumcuoglu KY, Huberman L, Cohen R, Temper V, Adler A, Galun R, Block C. Elimination of symbiotic Aeromonas spp. from the intestinal tract of the medicinal leech, Hirudo medicinalis, using ciprofloxacin feeding. Clin Microbiol Infect. 2010;16(6):563–7.
8. Fenollar F, Fournier PE, Legré R. Unusual case of Aeromonas sobria cellulitis associated with the use of leeches. Eur J Clin Microbiol Infect Dis. 1999;18:72–3.
9. Bauters TG, Buyle FM, Verschraegen G, Vermis K, Vogelaers D, Claeys G, Robays H. Infection risk related to the use of medicinal leeches. Pharm World Sci. 2007;29(3):122–5.
10. Isenberg HD. In: Essential procedures for clinical microbiology. Washington DC: ASM Press, 1998. ISBN-10: 1555811256.
11. Graf K, Ott E, Vonberg RP, Kuehn C, Haverich A, Chaberny IF. Economic aspects of deep sternal wound infections. Euro J Cardiothorac Surg. 2009;37(4):893–6.
12. Weber WP, Zwahlen M, Reck S, Feder-Mengus C, Misteli H, Rosenthal R, et al. Economic burden of surgical site infections at European university hospital. Infect Control Hosp Epidemiol. 2008;29(7):623–9.
13. Glance LG, Stone PW, Mukamel DB, Dick AW. Increases in mortality, length of stay and cost associated with hospital-acquired infections in trauma patients. Arch Surg. 2011;146(7):794–801.
14. Boltz MM, Hollenbeak CS, Julian KG, Ortenzi G, Dillon PW. Hospital costs associated with surgical site infections in general and vascular surgery patients. Surgery. 2011;150(5):934–42.
15. Alfonso JL, Pereperez SB, Canoves JM, Martinez MM, Martinez IM, Martin-Moreno JM. Are we really seeing the total costs of surgical site infections? Wound Repair Regen. 2007;15:474–81.
16. Levine SM, Frangos SG, Hanna B, Colen K, Levine JP. Aeromonas septicemia after medicinal leech use following replantation of severed digits. Am J Crit Care. 2010;19(5):469–71.
17. AR Elyassi, Terres J, Rowshan HH. Medicinal leech therapy on head and neck patients: a review of literature and proposed protocol. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116(3):167–72.
18. van Alphen NA, Gonzalez A, McKenna MC, McKenna TK, Carlsen BT, Moran SL. Ciprofloxacin-resistant Aeromonas infection following leech therapy for digit replantation: report of 2 cases. J Hand Surg Am. 2014;39(3):499–502.
19. Zarb P, Amadeo B, Muller A, Drapier N, Vankerckhoven V, Davey P, Goossens H. On behalf of the ESAC-3 hospital care subproject Group. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chem. 2011;66:443–9.
20. Malcolm W, Nathwani D, Davey P, Cromwell T, Patton A, Reilly J, Cairns S, Bennie M. From intermittent antibiotic point prevalence surveys to quality improvement: experience in Scottish hospitals. Antimicrob Resist Infect Control. 2013;2(1):3.